NewcelX

NewcelX Gross Margin

Gross Margin of NewcelX (NCEL) as of Oct 21, 2026.

Gross Margin

-

Last updated:

Gross Margin of NewcelX is 2026 - . Gross Margin of NewcelX was 2025 - . It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

NewcelX Stock analysis

What does NewcelX do? NewcelX AG, based in Zurich, Switzerland, operates in the Health Care sector with a focus on Pharmaceuticals. The company, listed on 29 January 2021, develops therapeutics for neurobehavioral and neurocognitive disorders. With a small team of two employees, it serves customers globally, concentrating on innovative treatments for neurological conditions. NewcelX is one of the most popular companies on Eulerpool.

Frequently Asked Questions about NewcelX stock

On Eulerpool you can find the complete historical development of Gross Margin NewcelX since 2006 – with annual values, charts, and detailed analysis.

Gross Margin measures the percentage of revenue remaining after COGS. Higher gross margins indicate more efficient production and stronger pricing power.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Gross Margin's NewcelX with sector peers and the industry average to assess whether it is attractive.

To evaluate Gross Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Gross Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — NewcelX

All Key Metrics — NewcelX